Crestwood Advisors Group’s Acadia Healthcare ACHC Stock Holding History

Crestwood Advisors Group’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Buy	+8,334	New	+$214K	﹤0.01%	761

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Crestwood Advisors Group's ACHC Position: Q2 2026 in Review

Crestwood Advisors Group opened a new position in Acadia Healthcare (ACHC) in Q2 2026: 8,334 shares worth $246K. The stake represents ﹤0.01% of the portfolio and ranks #761 among its holdings.

313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

Crestwood Advisors Group held 8,334 shares of Acadia Healthcare worth $246K as of Q2 2026.
Acadia Healthcare was a new Crestwood Advisors Group position in Q2 2026.
Acadia Healthcare made up ﹤0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #761 holding.
313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.